Detalles de la búsqueda
1.
Managing hemolysis in serum neuron-specific enolase measurements - an automated algorithm for routine practice.
Scand J Clin Lab Invest
; : 1-5, 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38853575
2.
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.
J Intern Med
; 293(5): 648-655, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36843323
3.
Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases.
Rheumatology (Oxford)
; 2023 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37773994
4.
Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring.
Scand J Gastroenterol
; 58(8): 863-873, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36799155
5.
Humoral immune response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive medication: association to serum drug levels and disease type.
Scand J Gastroenterol
; 58(8): 874-882, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788656
6.
Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial.
Gastroenterology
; 160(4): 1085-1096.e5, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33227280
7.
Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial.
J Intern Med
; 292(3): 477-491, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35411981
8.
Drug Levels Associated With Optimal Discrimination Between Remission and Nonremission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease.
Ther Drug Monit
; 44(2): 290-300, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34387220
9.
Falsely markedly elevated 25-hydroxyvitamin D in patients with monoclonal gammopathies.
Clin Chem Lab Med
; 59(4): 663-669, 2021 03 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33119540
10.
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort.
Rheumatol Int
; 41(9): 1657-1665, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33944985
11.
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
JAMA
; 326(23): 2375-2384, 2021 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34932077
12.
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
JAMA
; 325(17): 1744-1754, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33944876
13.
Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease.
Scand J Gastroenterol
; 55(8): 884-890, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32631131
14.
The effect of infliximab in patients with chronic low back pain and Modic changes (the BackToBasic study): study protocol of a randomized, double blind, placebo-controlled, multicenter trial.
BMC Musculoskelet Disord
; 21(1): 698, 2020 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33087100
15.
A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients.
Ther Drug Monit
; 41(1): 11-18, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30633722
16.
Real world data on effectiveness, safety and therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease. A single center cohort.
Scand J Gastroenterol
; 54(1): 41-48, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30650312
17.
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome.
Br J Cancer
; 118(12): 1609-1616, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29872151
18.
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.
Lancet
; 389(10086): 2304-2316, 2017 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28502609
19.
Transplacental passage of belimumab during pregnancy and follow-up of a child exposed in utero.
Ann Rheum Dis
; 82(4): 577-579, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36604152
20.
Switching from originator to biosimilar infliximab - real world data of a prospective 18 months follow-up of a single-centre IBD population.
Scand J Gastroenterol
; 53(6): 692-699, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29852793